What caught my eye was the quote: "it is worth noting that we expect its operations to be profitable either with or without Chinese label infant formula registration approval." JAT can make profits in-spite of SRMA (whatever that acronym was). Our fortunes are not beholden to having the approval, though it may help.
Ann: Creation of New Brand and Release of New Products, page-4
Add JAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.0¢ |
Change
0.048(7.63%) |
Mkt cap ! $55.78M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 67.0¢ | 62.0¢ | $68.12K | 103.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3591 | 66.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.0¢ | 43507 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| JAT (ASX) Chart |